Skip to main content
Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone
HomeStocksAkums Drugs & Pharmaceuticals Ltd
Akums Drugs & Pharmaceuticals Ltd

Akums Drugs & Pharmaceuticals Ltd

Symbol:AKUMS
Small Cap
LTP765.65
-10.7 (-1.38%)
No chart data available for selected period

Fundamentals Ratios

Key Valuation Metrics

Market Cap₹12,216.92 Cr
P/E Ratio41.73
P/B Ratio5.03
Industry Ratio37.96
ROE7.70%
EPS (TTM)₹18.6
Dividend Yield0.38%
Book Value₹154.29
Face Value₹2
Sector P/E37.96
Outstanding Shares15.74 Cr
Beta0.92
Market Cap Type- -

Financial Statements

ParticularsMAR 2025MAR 2024MAR 2023MAR 2022
Sales Turnover4,118.164,178.183,654.823,671.89
Other Income68.8234.0390.0722.83
Total Revenue4,188.634,199.873,720.853,782.46
Total Expenditure3,655.324,068.893,411.53,864.33
Operating Profit533.3130.97309.36(81.86)
Interest34.650.6146.2516.66
Gross Profit498.780.36263.11(98.52)
Depreciation153.45125.64112.8194.68
Profit Before Tax345.25(45.28)150.3(193.2)
Tax80.9157.2579.7463.72
Net Profit343.780.7997.82(250.87)

About

Managing Director- -
Auditor NameWalker Chandiok & Co LLP
Founded2004
Parent OrganizationAkums Drugs & Pharmaceuticals Ltd

Price Summary

Open

₹780.25

Prev Close

₹776.35

Today's High

₹792

Today's Low

₹762.15

52W High₹796.55
52W Low₹409.3
Volume3,45,164
Traded ValueN/A

Shareholding Pattern

Foreign Promoters and Groups
Indian Promoters and Groups
Non-Promoter Institutions
Non-Promoter Non-Institutions

Data as per latest exchange filings*

Frequently Asked Questions

Common questions about this stock, answered from live data

As of 15 Sept 2026, 3:30 pm, the share price of Akums Drugs & Pharmaceuticals Ltd (AKUMS) is ₹765.65 on NSE and BSE.

Disclaimer: The FAQs above are generated based on historical and real-time market data provided by exchanges. This information is for educational purposes only and does not constitute financial advice, buy/sell recommendations, or price targets. Investment in the securities market is subject to market risks. Read all related documents carefully before investing.